Vir Biotechnology, entered a collaboration and license agreement with Gilead to discover and engineer three novel PRO-XTEN dual-masked T-cell engager development candidates target ...

Experts warn prediction markets are exposing gaps in pharma vendor confidentiality agreements, Roche licenses Rona ...

Roche licenses Rona Therapeutics’ ALK7-targeting RNAi candidate for obesity, while Pfizer partners with Enodia Therapeutics ...

Fox Rothschild's Mark Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and ...

Since prediction market platforms such as Kalshi began offering trade markets on regulatory reviews and clinical trial ...

Drug shortages remain a difficult to fix issue for the pharma industry and are an issue that can have devastating results.

Biotech startups face high failure rates, with nearly 90% failing and only 28% of first-time product launches exceeding forecasts. Early integration of commercialization strategies is crucial for ...

If AI is taking over the routine assignments that have traditionally supported an apprenticeship model, through which new ...

Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at LogiPharma 2026 in Boston. During the conversation., the ...

PaxSafe's Mark Talens on why pharma supply chain AI fails before it starts — and the data foundry framework that changes that. Pharmaceutical Executive spoke with Mark Talens, CCO of PAXAFE at ...

Caribou Biosciences discontinues its two allogeneic CAR-T programs, Kamal Biswas makes the case for continuous quality ...

Thomas Appio has been named interim CEO of Bausch + Lomb, a move coinciding with an expected upward revision to the company’s ...